ABIONYX Pharma
ABNX | PA
Overview
Corporate Details
- ISIN(s):
- FR0012616852 (+1 more)
- LEI:
- 969500785J7VIC5YPC96
- Country:
- France
- Address:
- 33 AVENUE GEORGES POMPIDOU, 31130 BALMA
- Website:
- https://abionyx.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones Thanks to its partners in research, medicine, its bioproduct suppliers and its shareholders, the company innovates on a daily basis to propose drugs for the treatment of renal and ophthalmological diseases, or new HDL vectors used for targeted drug delivery.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-06 21:33 |
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
|
English | 220.6 KB | |
| 2025-05-06 21:33 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 201.5 KB | |
| 2025-04-03 20:16 |
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
|
English | 220.6 KB | |
| 2025-04-03 20:16 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 201.4 KB | |
| 2025-03-21 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 253.8 KB | |
| 2025-03-21 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 221.7 KB | |
| 2025-03-17 18:00 |
Report Publication Announcement
Annual financial and audit reports / Terms of availability of the annual financ…
|
English | 199.5 KB | |
| 2025-03-17 18:00 |
Regulatory News Service
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
|
French | 193.4 KB | |
| 2025-03-05 07:30 |
Earnings Release
ABIONYX Pharma annonce ses résultats annuels 2024
|
French | 316.1 KB | |
| 2025-03-05 07:30 |
Earnings Release
ABIONYX Pharma Announces Its 2024 Full-Year Results
|
English | 232.0 KB | |
| 2025-03-04 18:00 |
Declaration of Voting Results & Voting Rights Announcements
ABIONYX Pharma : Information relative au nombre total de droits de vote et d’ac…
|
French | 190.2 KB | |
| 2025-03-04 18:00 |
Declaration of Voting Results & Voting Rights Announcements
ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the…
|
English | 179.6 KB | |
| 2025-02-27 19:20 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 222.1 KB | |
| 2025-02-27 19:20 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 228.3 KB | |
| 2025-01-13 18:00 |
Inside Information Statement
Inside Information / Other news releases
|
English | 229.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-02-28 | N/A | Other | Buy | 53,913 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS | |
|
Ascelia Pharma | Sweden | ACE |